Recruiting studies
Hot Flashes
Study
Managing hot flashes in women who have had breast cancer
About the study sponsored by Astellas:
Having had breast cancer means that you cannot take just any medication to reduce hot flashes.
In fact your options are very limited.
This is where this clinical study may be interesting for you.
The medication is specially designed to reduce hot flashes in women who have had breast cancer.
Why participate?
Contribute to the future of health: Your participation can play a crucial role in medical research with a drug potentially offering better reduction of hot flashes.
Access to top-notch healthcare: benefit from close medical monitoring by the team and free study-related exams and information on healthy lifestyles.
Financial compensation: To recognize your time and dedication to the cause, financial compensation may be considered for participants who meet the eligibility criteria.
Who is eligible?
We invite to participate women who:
- Are aged 18 and over
- Having had stage 1 to 3 breast cancer
How it works?
Pre-registration: Start by completing our online pre-registration form to help us determine if you may be eligible.
Initial Assessment: If you are considered pre-eligible, an invitation will be sent to you to come to our center for a detailed assessment.
Participation: After confirmation of your eligibility, you will receive all the information required to begin your participation in this study.
I want to apply to this clinical study
For more information, contact us at
819 346-2887 (Sherbrooke), 819 801-9797 (Trois-Rivières)
or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.
